This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the pricing of an underwritten ...

We recently compiled a list of the 13 AI News and Ratings on Wall Street’s Radar. In this article, we are going to take a ...

Blake Gwinn, the head of US Rates Strategy at RBC Capital Markets, joins Yahoo Finance's Morning Brief to explain why the ...

Analysts are evaluating the financial impact of the wildfires that have charred hillsides, homes, and streets in Los Angeles ...

A hot jobs report makes it even more likely the Federal Reserve won’t cut rates at its next meeting in January — or for the foreseeable future.

RBC has partnered with Cohere, a company specializing in security and privacy-focused enterprise AI, to co-develop North for ...

RBC Capital analyst Mike Dahl raised the firm’s price target on Vulcan Materials (VMC) to $269 from $259 and keeps a Sector Perform rating on ...

RBC Capital Markets raised its recommendation on KB Home (NYSE:KBH) and Lennar (NYSE:LEN), considering the homebuilders' ...

Investing.com -- Shares of Apellis Pharmaceuticals (NASDAQ: APLS) fell 8.9% in premarket trading following news that the FDA accepted a revised supplemental application from competitor Astellas Pharma ...

Daily roundup of research and analysis from The Globe and Mail’s market strategist Scott Barlow ...